CO5700727A2 - Procedimientos para preparar aminas enriquecidas estereoisomericamente - Google Patents

Procedimientos para preparar aminas enriquecidas estereoisomericamente

Info

Publication number
CO5700727A2
CO5700727A2 CO06052852A CO06052852A CO5700727A2 CO 5700727 A2 CO5700727 A2 CO 5700727A2 CO 06052852 A CO06052852 A CO 06052852A CO 06052852 A CO06052852 A CO 06052852A CO 5700727 A2 CO5700727 A2 CO 5700727A2
Authority
CO
Colombia
Prior art keywords
aryl
alkyl
cr7r8
halo
hydrogen
Prior art date
Application number
CO06052852A
Other languages
English (en)
Inventor
Shanghui Hu
Carlos Alberto Martinez
Junhua Tao
Yazbeck Daniel Rida
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO5700727A2 publication Critical patent/CO5700727A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/08Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/24Proline; Hydroxyproline; Histidine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

1.- Un procedimiento para preparar un compuesto enriquecido estereoisoméricamente de fórmula (I) en la que Z es O, S, C=O, C=CH2, o -(CR7R8)-;R1 es hidrógeno, -(CR7R8)-t(arilo C6-C14), -CH2-CH=CH2, -C(O)R7, -C(O)OR7, -C(O)C(O)OR7 o -Si(R7)3, en la que dicho arilo C6-C14 está opcionalmente sustituido con al menos un sustituyente seleccionado de halo, alquilo C1-C10, OR7 y -N(R7R8);R2 y R3 se seleccionan independientemente de hidrógeno, alquilo C1-C10, alquenilo C2-C10, alquinilo C2-C10, -(CR7R8)-t(arilo C6-C14) y -(CR7R8)t(heterociclo de 4-10 miembros), en la que el arilo C6-C14 y el heterociclo de 4-10 miembros están opcionalmente sustituidos con al menos un sustituyente seleccionado de halo, alquilo C1-C10, OR7, y -N(R7R8);R4 y R5 se seleccionan independientemente de hidrógeno, halo, alquilo C1-C10, alquenilo C2-C10, alquinilo C2-C10, -(CR7R8)-t(arilo C6-C14) y -(CR7R8)t(heterociclo de 4-10 miembros), en la que el arilo C6-C14 y el heterociclo de 4-10 miembros están opcionalmente sustituidos con al menos un sustituyente seleccionado de halo, alquilo C1-C10, -OR7, y -N(R7R8);R6 es hidrógeno;R7 y R8 se seleccionan cada uno independientemente de hidrógeno, halo, alquilo C1-C10, alcoxi C1-C10, alquenilo C2-C10, alquinilo C2-C10, -(CR9R9)t(arilo C6-C14) y -(CR9R9)-t(heterociclo de 4-10 miembros), en la que el arilo C6-C14 y el heterociclo de 4-10 miembros están opcionalmente sustituidos con al menos un sustituyente seleccionado de halo, alquilo C1-C10, -OR9, y -N(R9R9);cada R9 se selecciona independientemente de hidrógeno y alquilo C1-C10; y t es un número entero de 0 a 5;comprendiendo dicho procedimiento:tratar un compuesto de fórmula (I), en la que R1, R2, R3, R4 y R5 son tal como se han definido anteriormente y R6 se selecciona de alquilo C1-C10, alquenilo C2-C10, alquinilo C2-C10, -(CR7R8)-t(arilo C6-C14) y -(CR7R8)t(heterociclo de 4-10 miembros), y en la que dicho arilo C6-C14 y dicho heterociclo de 4-10 miembros están opcionalmente sustituidos con al menos un sustituyente seleccionado de halo, alquilo C1-C10, OR7, y -N(R7R8), con un biocatalizador en una solución acuosa, un disolvente orgánico, o una mezcla de disolventes orgánico y acuoso en la que se hidroliza selectivamente al menos un estereoisómero.
CO06052852A 2003-12-04 2006-06-01 Procedimientos para preparar aminas enriquecidas estereoisomericamente CO5700727A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52714303P 2003-12-04 2003-12-04

Publications (1)

Publication Number Publication Date
CO5700727A2 true CO5700727A2 (es) 2006-11-30

Family

ID=34652482

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06052852A CO5700727A2 (es) 2003-12-04 2006-06-01 Procedimientos para preparar aminas enriquecidas estereoisomericamente

Country Status (14)

Country Link
US (1) US20050192441A1 (es)
EP (1) EP1737818A2 (es)
JP (1) JP2007521801A (es)
KR (1) KR20060100457A (es)
CN (1) CN101068780A (es)
AU (1) AU2004295187A1 (es)
BR (1) BRPI0417046A (es)
CA (1) CA2549289A1 (es)
CO (1) CO5700727A2 (es)
IL (1) IL175737A0 (es)
NO (1) NO20062944L (es)
RU (1) RU2006119470A (es)
WO (1) WO2005054186A2 (es)
ZA (1) ZA200604545B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007026875A1 (ja) * 2005-09-02 2007-03-08 Ube Industries, Ltd. 光学活性(S又はR)-α-ヒドロキシ酸及び光学活性(R又はS)-α-ヒドロキシ酸エステルの製造方法
CN101284797B (zh) * 2008-06-11 2010-08-11 常州恩滋生物科技有限公司 N-保护的烯丙基甘氨酸酯的拆分方法
EP2373977A1 (en) * 2008-12-17 2011-10-12 The Lubrizol Corporation Optically active functional fluid markers
RU2014106109A (ru) * 2011-07-20 2015-08-27 Эвоник Дегусса Гмбх Окисление и аминирование первичных спиртов

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5644028A (en) * 1992-05-13 1997-07-01 Japan Energy Corporation Process for producing peptide derivatives and salts therefor
US5932550A (en) * 1995-06-30 1999-08-03 Japan Energy Corporation Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
US6222043B1 (en) * 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
CA2245543A1 (en) * 1996-03-13 1997-09-18 Fabienne Henzen Process for producing n-protected d-proline derivatives 8
AU5757498A (en) * 1996-12-16 1998-07-15 Lonza A.G. Method for production of d-proline derivatives
HN2002000136A (es) * 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis

Also Published As

Publication number Publication date
ZA200604545B (en) 2007-10-31
JP2007521801A (ja) 2007-08-09
KR20060100457A (ko) 2006-09-20
IL175737A0 (en) 2006-09-05
WO2005054186A2 (en) 2005-06-16
US20050192441A1 (en) 2005-09-01
BRPI0417046A (pt) 2007-02-06
RU2006119470A (ru) 2007-12-20
CN101068780A (zh) 2007-11-07
EP1737818A2 (en) 2007-01-03
NO20062944L (no) 2006-09-04
AU2004295187A1 (en) 2005-06-16
WO2005054186A3 (en) 2007-04-19
CA2549289A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
BR122012009489B8 (pt) processo para produzir 2-etóxi-1-{[2’-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso
AR062680A1 (es) Sintesis de 2-(piridin-2-ilamino) pirido [2,3-d] pirimidin-7-onas
CO5590957A2 (es) Amino-1,3,5-triazinas sustituidas en n con radicales biciclicos quirales, procedimiento para su preparacion, composiciones de las mismas y su uso como herbicidas y reguladores del crecimiento de las plantas
AR058546A1 (es) Derivados de 2- adamantilurea como inhibidores selectivos de 11 beta - hsd1
AR048669A1 (es) Derivados biciclicos de bisamida
AR061008A1 (es) Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo
AR061438A1 (es) Derivados de entacapone
AR050258A1 (es) Derivado de diamina, proceso de la preparacion de este, y fungicida que contiene el derivado de diamina como ingrediente activo
AR074648A1 (es) Derivados de isoxazolina que poseen un anillo de cuatro miembros como grupo terminal, intermediarios de sintesis, composiciones biocidas que los contienen y metodos para combatir y controlar dichas plagas
ECSP088397A (es) Derivados de amida heterociclica útiles como microbiocidas
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
PE20211205A1 (es) Inhibidores de la interaccion proteina-proteina keap1-nrf2
CO5700727A2 (es) Procedimientos para preparar aminas enriquecidas estereoisomericamente
AR021087A1 (es) Pirimidin-4-iliden-alquilamina 2,3-sustituida 5,6-anillada, composicion para controlar y prevenir plagas, uso de dichos compuestos para proteger a lasplantas contra la infestacion por microorganismos fitopatogenicos, metodo para controlar o prevenir la infestacion de plantas cultivadas por microorga
AR054272A1 (es) Derivados de 3- aminopirrilidinas tri, tetra - sustituidos
PE20151892A1 (es) Compuestos tetraciclicos sustituidos con heterociclo y metodos de uso de los mismos para el tratamiento de enfermedades viricas
AR053339A1 (es) Composiciones para el tratamiento del cabello y/o del cuero cabelludo
PE20210478A1 (es) Compuestos heteroaromaticos como inhibidores de vanina
ES2106185T3 (es) 3-carboxiesteroides 17-beta-sustituidos no saturados.
CO5550494A2 (es) Derivados de diamina, proceso para producir los derivados de diamina, y fungicidas que contienen los derivados de diamina como ingrediente activo
AR041786A1 (es) Derivados de azetidina como antagonistas del receptor ccr-3, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la elaboracion de un medicamento
PE20040750A1 (es) Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3
ZA201008029B (en) Novel amino acid derivatives,method for preparing same,and therapeutic use thereof
UY29684A1 (es) Derivados de piperidina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones
AR044676A1 (es) Pirrolidinas y piperidinas sustituidas, compuestos relacionados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FC Application refused